Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tetramethrin is a synthetic pyrethroid insecticide used for the control of household and agricultural pests. It acts as a nerve cell membrane **sodium channel modulator** in insects by interfering with the entrance of sodium ions into axonal channels. This leads to hyperactivity of the nervous system and ultimately paralysis or death in target pests. Tetramethrin is commonly formulated as a mixture of stereoisomers and is found in many commercial insecticide products for residential and commercial use. It has been classified as a Category 2 carcinogen by the European Commission Directorate-General for the Environment[5][7]. The compound was withdrawn from at least one region but remains registered for use in others[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tetramethrin.